Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Investors boost stakes in Organon & Co., as earnings exceed expectations and insiders buy shares.
The Illinois Municipal Retirement Fund and Oppenheimer & Co. Inc. have significantly increased their holdings in Organon & Co., with the latter seeing a 48.5% and 67.8% rise respectively.
Organon reported earnings per share of $1.02, exceeding expectations, and insiders have shown confidence by purchasing shares.
The company has a market cap of $2.57 billion and analysts predict 3.68 earnings per share for the year, with a "Moderate Buy" rating.
2 Articles
Los inversores aumentan las participaciones en Organon & Co., ya que las ganancias superan las expectativas y los conocedores compran acciones.